Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR1H4 | Q96RI1 | 4/20 | 0.44 |
| ▸ | PPARD | Q03181 | 5/20 | 0.39 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.39 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.39 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.39 |
| ▸ | GPBAR1 | Q8TDU6 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1246467 | 0.94 | NR1H4 (0.43) | NR1H4PPARDPTGS2GPBAR1SCN9A | |
| SCHEMBL1245358 | 0.92 | NR1H4 (0.42) | NR1H4PPARDPTGS2GPBAR1SCN9A | |
| SCHEMBL1246346 | 0.92 | SCN9A (0.38) | NR1H4PPARDGPBAR1SCN9AMAPT | |
| SCHEMBL1245136 | 0.90 | NR1H4 (0.38) | NR1H4PPARDTDP1MAPT | |
| SCHEMBL1246951 | 0.90 | CYP11B1 (0.40) | NR1H4PTGS2GPBAR1TDP1SCN9A | |
| SCHEMBL1246476 | 0.90 | NR1H4 (0.42) | NR1H4PPARDGPBAR1MAPT | |
| SCHEMBL1245176 | 0.89 | NR1H4 (0.40) | NR1H4PPARDGPBAR1SCN9AMAPT | |
| SCHEMBL1247166 | 0.88 | TSHR (0.44) | NR1H4PPARDTSHR | |
| SCHEMBL1247326 | 0.88 | PPARD (0.37) | NR1H4PPARDGPBAR1SCN9AMAPT | |
| SCHEMBL1245320 | 0.88 | NR1H4 (0.45) | NR1H4PTGS2GPBAR1TDP1SCN9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2462128-A2 | COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS | Amira Pharmaceuticals, Inc. (US) | 2012-06-13 | — | — | EP | claimed |
| WO-2011017350-A2 | COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS | AMIRA PHARMACEUTICALS, INC. (US) | 2011-02-10 | — | — | WO | claimed |